The pandemic of COVID-19 is the biggest public health crisis in 21 st Century. Besides the
acute symptoms after infection, patients and society are also being challenged by the long …

Introduction; Pulmonary fibrosis is a frequently reported COVID-19 sequela in which the
exact prevalence and risk factors are yet to be established. This meta-analysis aims to …

The long-term pulmonary outcomes of coronavirus disease 2019 (COVID-19) are unknown.
We aimed to describe self-reported dyspnoea, quality of life, pulmonary function and chest …

Long COVID or post-COVID-19 syndrome first gained widespread recognition among social
support groups and later in scientific and medical communities. This illness is poorly …

Post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection are debilitating, clinically heterogeneous and of unknown molecular etiology. A …

ABSTRACT Introduction: Coronavirus disease 2019 (COVID-19) is still increasing
worldwide, and as a result, the number of patients with pulmonary fibrosis secondary to …

METHODS Electronic databases, including PubMed, EMBASE, Cochrane Library, Science
Direct, Google Scholar, were systematically searched from the initiation of the database until …

Long-term sequel of acute COVID-19, commonly referred to as long COVID, has affected
millions of patients worldwide. Long COVID patients display persistent or relapsing and …

Pulmonary fibrosis (PF) is characterised by several grades of chronic inflammation and
collagen deposition in the interalveolar space and is a hallmark of interstitial lung diseases …

Rationale: Data on longitudinal recovery after hospitalization for coronavirus disease
(COVID-19) currently remain scarce, just as outcomes beyond 3 months of follow-up do …